March 21, 2024 12:57 PM EDTUpdated 04:19 PM
Pharma

Medicare and Med­ic­aid open cov­er­age of an­ti-obe­si­ty drugs for heart pa­tients

Zachary Brennan

Senior Editor

The Cen­ters for Medicare and Med­ic­aid Ser­vices said that an­ti-obe­si­ty drugs should be cov­ered for pa­tients get­ting them for ad­di­tion­al med­ical con­di­tions, a move that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times